Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivimed Labs has filed a Pre-pack Insolvency Resolution Process (PPIRP) application before the NCLT Bengaluru Bench on 12 February 2026 under Section 54A of the Insolvency and Bankruptcy Code. The company has reported a total default of about Rs. 512.53 crores as on 31 January 2026, signalling deep financial trouble. This is a follow-up to the company's earlier intimations dated 13 November 2025 and 10 January 2025, indicating that resolution efforts have been ongoing. The PPIRP route is a faster, less disruptive insolvency mechanism meant for companies in financial distress but still capable of running as a going concern.
This is a strongly negative development for shareholders, as the company has effectively entered formal insolvency proceedings with a very large default. Equity investors should brace for sharp downside moves, possible trading curbs, and high risk of equity dilution or wipe-out in any resolution plan, since creditors rank ahead of shareholders.